Abstract: Adult T-cell leukemia/lymphoma (ATLL) is a distinct disease caused by the first discovered human oncogenic retrovirus, human T-cell leukemia virus type-1 (HTLV-1). The peculiarity of this disease is not only in its causative agent HTLV-1 but also in the character of leukemia cells. 
Introduction
ATLL was proposed as a new disease entity in 1977 because of its limited distribution of the patients' birthplaces in the Kyushu area of Japan and more suggestively its peculiar clinical and laboratory findings [1] .
Hypercalcemia and involvement of the skin and visceral organs, especially that of the lung, liver, and gastro-intestinal tracts, are frequent signs of the disease, and ATLL cells show a characteristic morphology with multi-lobulated nuclei called flower cells (Fig. 1) . In 1981, its causative agent HTLV-1 was discovered [2] [3] , and the geographic clustering of the HTLV-1 carriers and HTLV-1-related diseases was recognized: Japanese in Asia, Melanesians in near Oceania, blacks in central Africa and the Caribbean basin, and American Indians in Central and South America [4] .
The regional clustering is explained by mother-to-child transmission of the virus by breast-feeding in closed communities [5, 6] . Although ATLL is an all encompassing term that is designed to highlight monoclonal nature of the disease and define it as a condition that involves the monoclonal proliferation of HTLV-1-infected T-lymphocytes (Fig. 2) , its clinical behavior is quite diverse among patients. ATLL is thus subclassified into four subtypes; the smoldering and chronic types are indolent subtypes and the acute and lymphoma types are aggressive subtypes [7] . Patients with the indolent subtypes survive several years even without chemotherapy, but the prognosis of the aggressive subtypes is extremely poor and their median survival time is only 13 months even in the recent multicenter clinical trial performed in Japan [8] .
One of the causes of poor prognosis comes from suppression of their immunosurveillance system, and the patients with aggressive subtypes are sometimes found with opportunistic infections such as Pneumocystis jiroveci pneumonia, fungal infection, or Cytomegalovirus infection before and/or during treatment (Table 1 ) [9] , which makes it difficult to start or continue chemotherapy.
Moreover, some patients show conditions similar to hyper-IgE syndrome that is characterized by recurrent staphylococcal infections of the skin, chronic eczema-like rashes, eosinophilia, and markedly elevated serum IgE levels [10, 11] . Another piece of evidence for the immunosuppression that occurs in ATLL is the low response to the tuberculin skin test that is used to assess the general status of individual cellular immunity in Japan. Since the BCG vaccination is given to all individuals who show a negative reaction to the test, 70 to 80% of Japanese around 60 years of age, the median age of ATLL patients, show a positive 4 reaction. The prevalence of positivity for the tuberculin skin test in acute type and lymphoma type ATLL patients is very low (15% and 25%, respectively), which is significantly different from its prevalence in other lymphoproliferative disorders (p<0.05) [12] . Notably, tuberculin skin test-negative patients produce a positive reaction after they have achieved complete remission [12] , suggesting that ATLL cells play an immunosuppressive activity in vivo.
The immunological characteristics of ATLL cells 1. T cell-related markers (Table 2) ATLL cells display an activated mature helper/inducer T-cell phenotype:
CD1-, CD2+, CD3+, CD4+, CD5+, CD7-, CD8-, and HLA-DR+ (Fig. 3 ) [13] .
T-cell receptors (TCR) are always α/β heterodimers and no patients with γ/δ heterodimers have been reported. The density of cell surface CD3/TCR molecules is usually low compared with normal T cells or other mature T-cell malignancies despite their high mRNA expression, and this discordance is also believed to be one of the characteristics of ATLL cells [14, 15] .
Although more than 80% cases show the CD4+CD8-phenotype, some cases show a double positive (CD4+CD8+), double negative (CD4-CD8-), or even 5 CD8+ single positive phenotype [16, 17] . Loss of CD2 and/or CD5 antigens is also not rare, and the prognosis of these aberrant cases is usually poor [16] .
Moreover, ATLL cells sometimes change surface phenotype to aberrant forms, gain CD8 or lose CD4, at relapse or at the exacerbation phase [18, 19] . with a few exceptional cases being CD45RA+CD45RO+ double positive [19] .
Consistent CD45RO expression interpreted as indicating that the target cells for HTLV-I-induced neoplastic transformation are helper memory T cells. Alternatively, this may simply reflect the activated T cell nature of ATLL cells because it has been reported that CD45RO expression is induced following T-cell activation [20] .
ATLL cells express CD30 [21, 22] , a member of the TNF receptor superfamily known to be expressed on activated T and B cells, and this result also supports the idea that ATLL cells are in an activated phase.
Elevated CD30 expression is considered one of the causes of the constitutive 6 NF-κB activation observed in ATLL cells, which is believed to be involved in ATLL oncogenesis [22, 23] . Another T cell activation marker, CD44, is also expressed in ATLL cells [24] . In contrast, although CD26/dipeptidyl peptidase IV is also known to be upregulated during T cell activation, ATLL cells either lack it or profoundly down-regulate its expression [25, 26] . The pathological significance of this down-regulation has not been elucidated. Table 2) Helper T cells are divided into two subsets, T helper 1 (Th1) and T helper 2 (Th2), according to their cytokine production patterns [27] . PTHrP [30, 31] . Accordingly, the unexpected production of IL-6 in ATLL cells may be attributable to the Tax protein, or alternatively, the Th1-Th2-dichotomy may not be fitting to determine neoplastic cell origins. Th17, another newly described lineage of CD4 T cells, is characterized by the production of IL-17, IL-17F, and IL-6 [32] .
Cytokines and cytokine receptors (

Although it has been demonstrated that the skewing of helper T cells toward either Th17 cells or
Treg cells is mutually exclusive in murine systems [32, 33] , there is no such evidence in humans [34] . It has been reported that Tax protein induces IL-17 gene expression in T cells [35] , but IL-17 production in primary ATLL cells has not yet been examined.
In contrast to such ambiguous cytokine production, ATLL cells show a distinct cytokine receptor expression profile. One of the most characteristic features is the expression of the IL-2 receptor (IL-2R) αchain (CD25) [36] .
IL-2R consists of three components, the α-chain, β-chain, and γ-chain. 3. Chemokines and chemokine receptors ( Moreover, ATLL skin lesions contain abundant transcripts of CCR4, CCL17, and CCL22, indicating a significant role for CCR4 expression in skin invasion. Another skin-homing chemokine receptor CCR10, which is expressed in a fraction of CLA+ T cells [52, 53] , is also expressed in ATLL cells, and ATLL cells migrate toward its ligand, CCL27 (cutaneous T-cell attracting chemokine: CTACK) [49] . These results indicate that ATLL cells have a high affinity for the skin. In fact, a variety of skin lesions, erythema, papules, and nodule-or tumor-formations are observed in more than one third of ATLL patients from the first diagnosis. Another unique characteristic is that ATLL cells not only express CCR8 but also produce its ligand CCL1 (I-309) [54] . Since CCL1 inhibits the apoptosis of ATLL cells, an anti-apoptotic autocrine mechanism is suggested [54] .
IL-2R
4. Other cell surface markers ( 
Regulatory T cells (Treg cells)
More than 30 years ago, two groups proposed the concept of suppressor T cells [64] [65] [66] . They aimed to disclose the suppression mechanism and asserted that the activity was mediated by antigen-specific suppressor cells.
They, however, ceased this assertion by the middle of 1980s and stopped using the term "suppressor T cells", mostly because they had failed to clone suppressor factors and to identify the responsible gene I-J locus [67] [68] [69] [70] . In a different stream of immune suppression study, Nishizuka and Sakakura showed that neonatal thymectomy in normal mice resulted in the development of an autoimmune disease [71] . Later, Sakaguchi et al.
showed that depletion of Lyt-1 (CD5) cells from adult mice resulted in the development of autoimmune diseases, whereas depletion of Lyt-2 (CD8) cells did not, suggesting the existence of suppressor T cells in the CD5+CD8-cell population [72] . They, thereafter, confirmed that the suppressor cells (currently termed Treg cells) existed in the CD4+ T cell fraction [73] .
Interestingly, the suppressor activity was mediated by CD4+ T cells mRNA levels [102] . The expression of OX40 in ATLL cells was shown long time ago, and was interpreted to be involved in leukemic cell infiltration [104] . In recent functional analyses of ATLL cells, it was confirmed that ATLL cells inhibit Concanavalin A-and anti CD3 antibody-stimulated T cell proliferation in a dose dependent manner not only in an allogeneic setting but also in autologous setting [99, [101] [102] [103] . The activities were not abrogated by antibodies against TGF-β or IL-10, which excludes the participation of these molecules in the suppression mechanism [101] . The lack of IL-2 production is also one of the key markers for Treg cells [73, 74] 
